Assessment of Rosacea Patients' Clinical Trial Experiences
Launched by POWER LIFE SCIENCES INC. · Feb 17, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the experiences of patients with rosacea who participate in medical research studies. Researchers want to learn what factors might make it hard for patients to join or complete these trials. By collecting information from a diverse group of rosacea patients, the study aims to identify trends and insights that could help improve future clinical trials for others dealing with this skin condition.
To be eligible for this trial, participants need to be at least 18 years old and have a diagnosis of rosacea. They should be able to understand the study’s procedures and agree to participate by signing a consent form. However, pregnant or breastfeeding women and those currently involved in other research studies will not be able to join. Participants can expect to share their experiences and insights about the clinical trial process, which will contribute to improving future studies for rosacea patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient is at least 18 years of age
- • Diagnosis of Rosacea
- • Ability to understand the study procedures, benefits and risks, and sign a written informed consent document.
- Exclusion Criteria:
- • Inability to perform regular electronic reporting
- • Women who are pregnant, intend to become pregnant, or are lactating
- • Enrolled in another research study
About Power Life Sciences Inc.
Power Life Sciences Inc. is a forward-thinking clinical trial sponsor dedicated to advancing innovative therapeutic solutions across various medical disciplines. With a strong emphasis on scientific rigor and patient-centered approaches, the organization collaborates with leading researchers and healthcare professionals to design and execute clinical trials that prioritize safety, efficacy, and compliance. Power Life Sciences Inc. leverages cutting-edge technology and data analytics to streamline trial processes, enhance participant engagement, and accelerate the development of life-changing treatments, ultimately aiming to improve patient outcomes and contribute to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Michael B Gill
Study Director
Power Life Sciences Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials